Stage 1: claimed.
The rule that placed itA company we follow says, in a passage we checked word for word, that its AI can do the task.
The evidenceDoNotPay (company marketing, as quoted by the FTC) says it can. US Federal Trade Commission, DoNotPay case page, Sep 25, 2024.
A stage says how far the evidence has got. It is not a rating of the AI and not advice.
- 1ClaimedPlaced here
- 2LaunchedNo evidence yet
- 3Independently testedNo evidence yet
- 4Tested with real peopleNo evidence yet
- 5Regulator-clearedNo approval process exists
- 6Widely used with a verified recordNo evidence yet
Everything we found.
In ladder order, newest first within each kind. Makers' own claims are labeled as theirs.
What the makers claim
- DoNotPay (company marketing, as quoted by the FTC)
“the world's first robot lawyer”
US Federal Trade Commission, DoNotPay case page · Sep 25, 2024 · company-reported
Rules and approvals
- US · Enforcement action · US Federal Trade Commission
The FTC ordered DoNotPay to pay $193,000 and stop advertising that its service performs like a real lawyer without evidence, after finding it never tested its legal documents against a lawyer's work.
“the company did not test whether its “AI lawyer” operated to the level of a human lawyer”
US Federal Trade Commission · Feb 11, 2025
Not found in our sources yet: what has launched; what independent tests found; tested with real people; how many people use it. No regulator approves AI for this task, so the approval step doesn't apply.
Track record and tools.
Failures and court cases are shown beside the stage, never folded into it. Tools are listed because the evidence names them, in no order of merit.
- DoNotPayDoNotPay
Can AI do these yet?

Answer my health questions
Stage 4 of 6Tested with real people
Randomized trial: chatbot users made no better health decisions

Spot breast cancer on a mammogram
Stage 5 of 6Regulator-cleared
Transpara has been FDA-cleared since 2018, most recently in Aug 2026

Check a mole for skin cancer
Stage 5 of 6Regulator-cleared
EU Class III CE mark lets DERM clear benign cases alone (company)
